CD86 and neoplasm: Results show that C3AR1 has the strongest correlation with M2 macrophages (CD163, MRC1, CD209), tumor-associated macrophages (CCL2, CD86, CD68) and monocyte immune markers, including (CD14, CD33, ITGAX) (Fig. 4B-D).